ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 226 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,670,353 | +47.0% | 34,930 | +9.6% | 0.32% | +32.1% |
| Q3 2023 | $1,136,593 | -5.1% | 31,882 | +22.8% | 0.24% | +1.2% |
| Q2 2023 | $1,198,088 | +1042.2% | 25,972 | +1047.2% | 0.24% | +135.3% |
| Q4 2022 | $104,891 | +41.7% | 2,264 | +26.1% | 0.10% | +50.0% |
| Q3 2022 | $74,000 | -57.5% | 1,795 | -38.5% | 0.07% | -48.5% |
| Q2 2022 | $174,000 | +3.0% | 2,918 | +25.5% | 0.13% | +65.0% |
| Q1 2022 | $169,000 | – | 2,326 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 497,899 | $31,617,000 | 3.20% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 390,453 | $24,794,000 | 1.81% |
| First Light Asset Management, LLC | 180,017 | $11,431,000 | 1.59% |
| Rock Springs Capital Management LP | 580,000 | $36,830,000 | 1.33% |
| Capital Impact Advisors, LLC | 36,165 | $2,244,000 | 0.82% |
| SECTOR GAMMA AS | 79,653 | $5,058,000 | 0.81% |
| Verity Asset Management, Inc. | 7,193 | $457,000 | 0.51% |
| Opus Point Partners Management, LLC | 5,064 | $322,000 | 0.48% |
| Capital International Sarl | 52,000 | $3,302,000 | 0.46% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 6,216 | $394,000 | 0.43% |